在多发性硬化症中,身体活动和认知功能之间是否存在值或剂量反应关联?
Brenda Jeng1, Gary R Cutter2, Robert W Motl1
1Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA.
概括
增加每天的步骤可能会改善多发性硬化症 (MS) 的认知功能. 在每天的步骤和认知测试得分之间发现了线性关系,这表明所有活动水平都有好处.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 临床神经学 临床神经学
背景情况:
- 认知障碍是多发性硬化症 (MS) 的一个重大挑战,影响日常生活和疾病管理.
- 身体活动,特别是每天的步数,已经显示出与多发性硬化症患者的认知健康的潜在联系.
研究的目的:
- 调查是否存在特定的每日步骤值,以避免MS患者的认知障碍.
- 确定MS患者的日常步骤和认知功能之间是否存在剂量反应关系.
主要方法:
- 358名患有多发性硬化症的参与者完成了认知测试 (SDMT,CVLT-II) 并佩戴加速度计7天,以测量每天的步骤.
- 收集了人口和临床数据,包括MS类型和残疾状况.
主要成果:
- 在SDMT或CVLT-II.II上没有特定的步骤/天值被确定为缺乏认知障碍.
- 回归分析显示,SDMT和CVLT-II的步骤/天和认知分数之间存在显著的线性关系.
结论:
- 在MS的日常步骤和认知功能之间存在线性关联,这表明更高的身体活动水平可能会提高认知表现.
- 对于患有多发性硬化症的人来说,无论他们目前的活动水平如何,鼓励他们每天增加步骤可能是对认知健康有益的策略.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...


